Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: Prospective multicenter study

Radiology

Volumn 232, Issue 3, 2004, Pages 799-809

  Bryant, Thomas H ^a   Blomley, Martin J ^a   Albrecht, Thomas ^b   Sidhu, Paul S ^c   Leen, Edward L S ^d   Basilico, Raffaella ^e   Pilcher, James M ^f   Bushby, Lucy H ^c   Hoffmann, Christian W ^b   Harvey, Christopher J ^a   Lynch, Madeleine ^a   MacQuarrie, John ^d   Paul, Dennis ^g   Cosgrove, David O ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

^e UNIVERSITY OF CHIETI   (Italy)

^f ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g Siemens Ultrasound   (United States)

Author keywords

Liver neoplasms; Liver neoplasms, diagnosis; Liver neoplasms, US; Microbubbles Ultrasound (US), contrast media

Indexed keywords

CONTRAST MEDIUM; SHU 508;

ADULT; AGED; ARTICLE; B SCAN; BILE DUCT CARCINOMA; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; ECHOGRAPHY; FEMALE; HUMAN; LIVER ADENOMA; LIVER BIOPSY; LIVER DISEASE; LIVER HEMANGIOMA; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGIST; STATISTICAL ANALYSIS; TISSUE SPECIFICITY; TUMOR DIAGNOSIS; ULTRASOUND;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROBUBBLES; MIDDLE AGED; POLYSACCHARIDES; PROSPECTIVE STUDIES;

EID: 4143139633     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2323030596     Document Type: Article

References (26)

1. Blomley MJ, Albrecht T, Cosgrove DO, et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology 1999; 210:409-416.
2. Schlief R. Developments in echo-enhancing agents. Clin Radiol 1996; 51(suppl 1): 5-7.
3. Blomley MJ, Albrecht T, Cosgrove DO, et al. Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist in normal volunteers and patients with and without liver disease. Ultrasound Med Biol 1999; 25:1341-1352.
4. Harvey CJ, Blomley MJ, Cosgrove DO. Acoustic emission imaging. In: Goldberg BB, Raichlen JS, Forsberg F, eds. Ultrasound contrast agents: basic principles and clinical applications. 2nd ed. London, England: Dunitz, 2001; 71-80.
5. Blomley MJ, Sidhu PS, Cosgrove DO. Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? early experience. Radiology 2001; 220: 661-667.
6. Bertolotto M, Dalla Palma L, Quaia E, Locatelli M. Characterisation of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results. Eur Radiol 2000; 10: 1369-1376.
7. von Herbay A, Vogt C, Häussinger D. Late-phase pulse inversion sonography using the contrast agent Levovist: differentiation between benign and malignant focal lesions of the liver. AJR Am J Roentgenol 2002; 179:1273-1279.
8. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumors: contrast agent enhancement patterns with pulse-inversion harmonic US. Radiology 2000; 216:411-417.
9. Dill-Macky MJ, Burns PN, Khalili K, Wilson SR. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology 2002; 222:95-102.
10. Altman DG. Practical statistics for medical research. London, England: Chapman & Hall, 1991; 404-408.
11. Albrecht T, Blomley MJ, Burns P. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003; 227:361-370.
12. Tumeh SS. The abdominal contents. In: Maisey MN, Brittion KE, Collier BD, eds. Clinical nuclear medicine. New York, NY: Chapman & Hall, 1998; 485-516.
13. Mergo P, Ros P. Benign lesions of the liver. Radiol Clin North Am 1998; 36: 319-331.
14. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999; 210:459-466.
15. Torres CG, Lundby B, Tufte Sterud A, Mcgill S, Gordon PB, Strand Bjerknes H. MnDPDP for MR imaging of the liver: results from the European phase III studies. Acta Radiol 1997; 38:631-637.
16. Oudkerk M, Torres CG, Song B, König M, et al. Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase CT. Radiology 2002; 223:517-524.
17. Pirovano G, Vanzulli A, Marti-Bonmati L, et al. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions. AJR Am J Roentgenol 2000; 175:1111-1120.
18. Grandin C, Van Beers BE, Robert A, Gigot JF, Geubel A, Pringot J. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. J Comput Assist Tomogr 1995; 19:412-418.
19. Quaia E, Bertolotto M, Dalla Palma L. Characterization of liver hemangiomas with pulse inversion harmonic imaging. Eur Radiol 2002; 12:537-544.
20. Winston CB, Schwartz LH, Fong Y, Blumgart LH, Panicek DM. Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers. Radiology 1999; 210:75-79.
21. Brancatelli G, Federle MP, Grazioli L, Carr BI. Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 U.S. residents. Radiology 2002; 222:89-94.
22. Dodd GD 3rd, Baron RL, Oliver JH 3rd, Federle MP. Spectrum of imaging findings of the liver in end stage cirrhosis. II. Focal abnormalities. AJR Am J Roentgenol 1999; 173:1185-1192.
23. Brancatelli G, Federle MP, Blachar A, Grazioli L. Hemangioma in the cirrhotic liver: diagnosis and natural history. Radiology 2001; 219:69-74.
24. Murakami T, Baron RL, Peterson MS, et al. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 1996; 200:69-77.
25. Ni Y, Marchal G, Zhang X, et al. The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. Invest Radiol 1993; 28:520-528.
26. Kitamura H, Kawasaki S, Nakajima K, Ota H. Correlation between microbubble contrast-enhanced color Doppler sonography and immunostaining for Kupffer cells in assessing the histopathologic grade of hepatocellular carcinoma: preliminary results. J Clin Ultrasound 2002; 30:465-471.